Two patients exceed 14 months on treatment in Phase 2 trial of advanced ovarian cancer; Allarity maintains a cash balance of $18.5 million, sufficient to advance and accelerate st ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback